In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo Co. PLC

www.perrigo.com

Latest From Perrigo Co. PLC

GSK And Perrigo Issue Recalls In Sweden After Metal Staple Found In Rectal OTC

A metal staple found in GSK's Alvedon children's pain relief product in Sweden has prompted a recall which also encompasses Perrigo's Panodil brand.
Product Recalls OTC Drugs

Perrigo Prioritizes Innovating First After Following OTC Brands To Market

Perrigo’s "national brand better" approach includes adding "better" value to generic equivalents that branded aren't offering, says President and CEO Murray Kessler. Prevacid 24 HR acquisition puts Perrigo at top of 15-mg lansoprazole PPI brand sales as well as in the generics market.

OTC Drugs Commercial

Perrigo Feeds OTC Brand Play With Prevacid As GSK Thins Consumer Lineup

Already providing generic equivalents, Perrigo buys national brand from GSK as it acts on commitment to move into brand product sales. Plans to expand OTC Prevacid line, likely with an orally disintegrating tablet, and to grow entire US OTC gastrointestinal category.

OTC Drugs Commercial

Apotex' Aleve PM Rival Could Have 180-Day Exclusivity As A CGT

US consumers currently don't have access to enough private label/store brand competition for Aleve PM (naproxen/diphenhydramine), the FDA decides in granting Apotex its first OTC ANDA approval with Competitive Generic Therapy designation and eligibility for a type of exclusivity unlike any other previously allowed for OTCs.

United States Regulation
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register